Rekombinanter SSX2IP Antikörper

Produktnummer ABIN7882415

Der Kaninchen Monoklonal anti-SSX2IP Antikörper (Klon 30S65) (ABIN7882415) detektiert spezifisch SSX2IP in WB und IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für Rekombinanter SSX2IP Antikörper (ABIN7882415)

Target: SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser SSX2IP Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Klon: 30S65

Produktdetails anti-SSX2IP Antikörper

Verwendungszweck: SSX2IP Antibody / Synovial sarcoma X breakpoint protein 2 interacting protein

Aufreinigung: Affinity-chromatography

Immunogen: A synthesized peptide derived from human SSX2IP was used as the immunogen for the SSX2IP antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the SSX2IP antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store the SSX2IP antibody at -20oC.

Details zu SSX2IP

Target: SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))

Andere Bezeichnung: SSX2IP

Hintergrund: SSX2IP antibody detects synovial sarcoma X breakpoint protein 2 interacting protein, a centrosomal protein involved in cell division and spindle organization. SSX2IP contributes to centrosome maturation and stability, facilitating accurate chromosome segregation. It has also been implicated in ciliogenesis, reflecting its role in microtubule-based processes beyond mitosis.

Research using SSX2IP antibody has linked the protein to cancer progression. Altered expression of SSX2IP has been observed in hematologic malignancies and solid tumors, where it may affect proliferation and genomic stability. SSX2IP also plays a role in cell adhesion and migration, adding to its importance in tumor biology. In developmental contexts, its regulation of ciliogenesis connects it to congenital disorders tied to defective ciliary signaling.

Antibodies against SSX2IP are applied in western blot, immunofluorescence, and immunohistochemistry. These reagents enable investigation of centrosome integrity, mitotic processes, and ciliary dynamics. Clone validation ensures reproducible results across research applications.

NSJ Bioreagents supplies this SSX2IP antibody for studies in cell cycle regulation, cancer biology, and ciliary function. Alternate names include synovial sarcoma X breakpoint protein 2 interacting protein antibody, AF-15q14 antibody, and centrosomal protein SSX2IP antibody.

UniProt: Q9Y2D8